Puig-Tintoré LM - Search Results

1

Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.

Rovirosa A, Ascaso C, Ordi J, Abellana R, Arenas M, Lejarcegui JA, Pahisa J, Puig-Tintoré LM, Mellado B, Armenteros B, Iglesias X, Biete A. Rovirosa A, et al. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1320-9. doi: 10.1016/s0360-3016(01)02808-5. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955745

2

Prospective evaluation of squamous cell carcinoma and carcinoembryonic antigen as prognostic factors in patients with cervical cancer.

Molina R, Filella X, Lejarcegui JA, Pahisa J, Torné A, Rovirosa A, Mellado B, Ordi J, Puig-Tintore LM, Alicarte J, Biete A, Iglesias J. Molina R, et al. Tumour Biol. 2003 May-Jun;24(3):156-64. doi: 10.1159/000073846. Tumour Biol. 2003. PMID: 14610320

3

Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma.

Puig-Tintoré LM, Ordi J, Vidal-Sicart S, Lejárcegui JA, Torné A, Pahisa J, Iglesias X. Puig-Tintoré LM, et al. Gynecol Oncol. 2003 Jan;88(1):29-34. doi: 10.1006/gyno.2002.6857. Gynecol Oncol. 2003. PMID: 12504623

4

Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.

Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Campo E, Pahisa J, Ordi J. Alonso I, et al. Gynecol Oncol. 2006 Nov;103(2):631-6. doi: 10.1016/j.ygyno.2006.04.016. Epub 2006 Jun 14. Gynecol Oncol. 2006. PMID: 16780934

5

Is MRI helpful in evaluating the response of cervical cancer to neoadjuvant chemotherapy?

Vives A, Castelo-Branco C, Iglesias X, Tomás X, Palombo H, Pahisa J, Lejárcegui JA, Salvador A, Puig-Tintoré L. Vives A, et al. Acta Obstet Gynecol Scand. 1995 Jul;74(6):467-71. doi: 10.3109/00016349509024411. Acta Obstet Gynecol Scand. 1995. PMID: 7541596

6

High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.

Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Garcia S, Campo E, Pahisa J, Ordi J. Alonso I, et al. Among authors: puig tintore lm. Am J Obstet Gynecol. 2007 Oct;197(4):359.e1-6. doi: 10.1016/j.ajog.2007.01.023. Epub 2007 Aug 21. Am J Obstet Gynecol. 2007. PMID: 17714678

7

Clinical role of cervical cancer vaccination: when and whom to vaccinate?

Torné A, Alonso I, Puig-Tintoré LM, Pahisa J. Torné A, et al. Among authors: puig tintore lm. Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S15-6. doi: 10.1016/j.ygyno.2008.06.015. Epub 2008 Jul 17. Gynecol Oncol. 2008. PMID: 18635253

8

Human papillomavirus load in Hybrid Capture II assay: does increasing the cutoff improve the test?

Ordi J, Alonso I, Torné A, Esteve R, Sierra E, Campo E, Puig-Tintoré LM. Ordi J, et al. Gynecol Oncol. 2005 Nov;99(2):313-9. doi: 10.1016/j.ygyno.2005.07.011. Epub 2005 Aug 19. Gynecol Oncol. 2005. PMID: 16112180

9

Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain.

Puig-Tintoré LM, Castellsagué X, Torné A, de Sanjosé S, Cortés J, Roura E, Méndez C, Bosch FX. Puig-Tintoré LM, et al. J Low Genit Tract Dis. 2008 Apr;12(2):82-9. doi: 10.1097/LGT.0b013e3181599c16. J Low Genit Tract Dis. 2008. PMID: 18369300

10

The use of sentinel lymph nodes in gynaecological malignancies.

Torné A, Puig-Tintoré LM. Torné A, et al. Curr Opin Obstet Gynecol. 2004 Feb;16(1):57-64. doi: 10.1097/00001703-200402000-00011. Curr Opin Obstet Gynecol. 2004. PMID: 15128009 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters